Roberto Mignone
Director at Guardant Health, Inc. (GH) since October 2024
Roberto Mignone has filed 32 insider reports with the SEC since June 2021, as director at Guardant Health, Inc. (GH) and director at Teva Pharmaceutical Industries Ltd (TEVA). In the last 12 months Roberto Mignone sold $18M of stock on the open market. The latest filing, on September 22, 2026, reports exercise or conversion of a derivative at Guardant Health, Inc. (GH).
- Filings
- 32
- Companies
- 2
- Bought on market
- None
- Sold on market
- $38M
Companies where Roberto Mignone is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince October 2024 | 10,274 | $145.14 | Sep 22, 2026 | ||||
| Director | 119,807 | $38M | $42.23 | Sep 22, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 21, 2026GHDirector Mignone Roberto converted options into 264 shares, increasing direct ownership by 3% to 10,274 unitsForm 4Exercise or conversion of a derivative
- Sep 18, 2026-$14.4MTEVADirector Mignone Roberto sold $14,356,802 worth of Ordinary Shares (367,600 units at $39.06)Form 4Open-market sale
- Aug 21, 2026GHDirector Mignone Roberto converted options into 264 shares, increasing direct ownership by 3% to 10,010 unitsForm 4Exercise or conversion of a derivative
- Jul 21, 2026GHDirector Mignone Roberto converted options into 264 shares, increasing direct ownership by 3% to 9,746 unitsForm 4Exercise or conversion of a derivative
- Jun 21, 2026GHDirector Mignone Roberto converted options into 528 shares, increasing direct ownership by 6% to 9,482 unitsForm 4Exercise or conversion of a derivative
- Jun 17, 2026GHDirector Mignone Roberto converted options into 4,203 shares, increasing direct ownership by 88% to 8,954 unitsForm 4Grant or awardExercise or conversion of a derivative
- Jun 5, 2026TEVADirector Mignone Roberto converted options into 14,492 units of Ordinary Shares, increasing direct ownership by 14% to 119,807 unitsForm 4Exercise or conversion of a derivative
- May 28, 2026TEVASEC Form 4 filed by Director Mignone RobertoForm 4Grant or award
- Apr 21, 2026GHSEC Form 4 filed by Mignone RobertoForm 4Exercise or conversion of a derivative
- Mar 21, 2026GHSEC Form 4 filed by Mignone RobertoForm 4Exercise or conversion of a derivative
- Feb 21, 2026GHDirector Mignone Roberto converted options into 264 shares, increasing direct ownership by 7% to 4,223 unitsForm 4Exercise or conversion of a derivative
- Jan 21, 2026GHDirector Mignone Roberto converted options into 264 shares, increasing direct ownership by 7% to 3,959 unitsForm 4Exercise or conversion of a derivative
- Dec 21, 2025GHDirector Mignone Roberto converted options into 264 shares, increasing direct ownership by 8% to 3,695 unitsForm 4Exercise or conversion of a derivative
- Dec 16, 2025-$2.34MTEVADirector Mignone Roberto sold $2,340,646 worth of Ordinary Shares (77,400 units at $30.24)Form 4Open-market sale
- Nov 26, 2025-$1.3MTEVADirector Mignone Roberto sold $1,301,505 worth of Ordinary Shares (50,000 units at $26.03)Form 4Open-market sale
- Nov 21, 2025GHDirector Mignone Roberto converted options into 264 shares, increasing direct ownership by 8% to 3,431 unitsForm 4Exercise or conversion of a derivative
- Nov 6, 2025-$4.82MTEVADirector Mignone Roberto sold $4,821,880 worth of Ordinary Shares (200,000 units at $24.11)Form 4Open-market sale
- Oct 21, 2025GHDirector Mignone Roberto converted options into 3,167 sharesForm 4Exercise or conversion of a derivative
- Jun 18, 2025GHSEC Form 4 filed by Director Mignone RobertoForm 4Grant or award
- Jun 6, 2025TEVADirector Mignone Roberto converted options into 9,632 units of Ordinary Shares, increasing direct ownership by 10% to 105,315 unitsForm 4Grant or awardExercise or conversion of a derivative
- Dec 20, 2024-$6.29MTEVADirector Mignone Roberto sold $6,294,031 worth of Ordinary Shares (286,000 units at $22.01)Form 4Open-market sale
- Nov 8, 2024GHSEC Form 4 filed by Director Mignone RobertoForm 4Grant or award
- Oct 21, 2024GHNew insider Mignone Roberto claimed no ownership of stock in the companyForm 3New insider
- Jun 18, 2024-$8.84MTEVADirector Mignone Roberto sold $8,838,570 worth of Ordinary Shares (519,000 units at $17.03)Form 4Open-market sale
- Jun 15, 2024TEVADirector Mignone Roberto converted options into 21,108 units of Ordinary Shares, increasing direct ownership by 1% to 1,595,683 unitsForm 4Exercise or conversion of a derivative
- Jun 6, 2024TEVASEC Form 4 filed by Mignone RobertoForm 4Grant or award
- Aug 4, 2023TEVASEC Form 4: Mignone Roberto converted options into 15,810 units of Ordinary Shares, increasing direct ownership by 1% to 1,574,575 unitsForm 4Exercise or conversion of a derivative
- Jun 15, 2023TEVASEC Form 4 filed by Mignone RobertoForm 4Grant or award
- Aug 4, 2022TEVASEC Form 4 filed by Mignone RobertoForm 4Grant or award
- Jun 14, 2022TEVASEC Form 4: Mignone Roberto converted options into 14,479 units of Ordinary Shares, increasing direct ownership by 33% to 58,765 unitsForm 4Exercise or conversion of a derivative
- Jun 14, 2021TEVASEC Form 4 filed by MIGNONE ROBERTOForm 4Grant or award
- Jun 5, 2021TEVASEC Form 4: MIGNONE ROBERTO converted derivative securities into 6,041 units of Ordinary Shares, increasing direct ownership by 24% to 31,618 unitsForm 4Exercise or conversion of a derivative
Compare Roberto Mignone with
- Roberto Mignone vs Alex M Azar II1 shared
- Roberto Mignone vs Musa Tariq1 shared
- Roberto Mignone vs Dov Bergwerk1 shared
- Roberto Mignone vs Kevin R Sayer1 shared
- Roberto Mignone vs Robert Parks1 shared
- Roberto Mignone vs Richard Daniell1 shared
Other insiders at the same companies
- Medina Manuel HidalgoGH
- Alex M Azar IIGH
- Musa TariqGH
- Dov BergwerkTEVA
- Kevin R SayerGH
- Robert ParksGH
- Richard DaniellTEVA
- Richard D FrancisTEVA
- Mark SabagTEVA
- Amir WeissTEVA
- David J BrailerTEVA
- John G. SaiaGH
- Terilyn J. MonroeGH
- Kumud KaliaGH
- Chris FreemanGH
- Darya ChudovaGH
Questions about Roberto Mignone
- What is Roberto Mignone's role at Guardant Health, Inc.?
- Roberto Mignone reports to the SEC as director at Guardant Health, Inc. (GH), according to the latest filing on September 22, 2026. Roberto Mignone has also filed as director at Teva Pharmaceutical Industries Ltd (TEVA).
- How many shares does Roberto Mignone own?
- After the latest filing that states it, Roberto Mignone directly owned 10,274 shares of Guardant Health, Inc. (GH) and 119,807 shares of Teva Pharmaceutical Industries Ltd (TEVA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Roberto Mignone bought or sold stock recently?
- The most recent open-market sale was on September 18, 2026: sold 367,600 shares of Teva Pharmaceutical Industries Ltd (TEVA) for $14.4M at an average of $39.06.
- How do I get alerts when Roberto Mignone files?
- Follow Roberto Mignone on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Roberto Mignone filed 3 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Roberto Mignone (SEC CIK 0001258394). Totals count each trade once, skipping amendments whose original is on file, from Jun 8, 2021 on. View on SEC EDGAR